Welcome to the Merck & Company Q3 sales and earnings conference call. [Operator instructions] This call is being recorded.

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

Program extended this year to Australia, New Zealand, Taiwan, South Korea ...

Thank you for standing by. Welcome to the Merck & Co. Q3 sales and earnings conference call. (Operator Instructions) This call is being recorded. If you have any objections, you may disconnect at this ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Merck's third-quarter financial performance in 2024 showcased robust worldwide sales growth of 4%, reaching $16.7 billion.

Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced ...

Award recipients to receive in-kind technologies and services to accelerate therapeutics to market Merck experts to provide consultation and training in qualification, risk assessment, and process ...

"Merck is committed to supporting exceptional biotech companies to both kickstart and streamline their journey from discovery to manufacturing with our grant program," said Chua Keng Hock, Senior ...